Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
$63.42
-1.3%
$64.99
$51.09
▼
$74.35
$501.02M0.62122,106 shs301,106 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
-1.26%-5.37%-1.14%-12.88%+21.56%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
$63.42
-1.3%
$64.99
$51.09
▼
$74.35
$501.02M0.62122,106 shs301,106 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
-1.26%-5.37%-1.14%-12.88%+21.56%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
2.61
Moderate Buy$63.42N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/AN/A17.94N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
$0.270.43%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/A

Insider Ownership

CompanyInsider Ownership
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
SPDR S&P Pharmaceuticals ETF stock logo
XPH
SPDR S&P Pharmaceuticals ETF
N/A7.90 millionN/ANot Optionable

Recent News About These Companies

XPH - State Street SPDR S&P Pharmaceuticals ETF
XPH: Healthcare Sector Dashboard For October
XPH: Dividendenhistorie, Rendite und Ex-Dividenden-Tag
State Street SPDR S&P Pharmaceuticals ETF (XPH)

New MarketBeat Followers Over Time

SPDR S&P Pharmaceuticals ETF stock logo

SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH

$63.42 -0.81 (-1.26%)
Closing price 11/19/2026 04:10 PM Eastern
Extended Trading
$63.41 -0.01 (-0.02%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.